JP2009503076A5 - - Google Patents

Download PDF

Info

Publication number
JP2009503076A5
JP2009503076A5 JP2008525054A JP2008525054A JP2009503076A5 JP 2009503076 A5 JP2009503076 A5 JP 2009503076A5 JP 2008525054 A JP2008525054 A JP 2008525054A JP 2008525054 A JP2008525054 A JP 2008525054A JP 2009503076 A5 JP2009503076 A5 JP 2009503076A5
Authority
JP
Japan
Prior art keywords
alkyl
phenyl
tetrahydro
pyrido
pyrimidine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008525054A
Other languages
English (en)
Japanese (ja)
Other versions
JP5066088B2 (ja
JP2009503076A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2006/029437 external-priority patent/WO2007019083A1/en
Publication of JP2009503076A publication Critical patent/JP2009503076A/ja
Publication of JP2009503076A5 publication Critical patent/JP2009503076A5/ja
Application granted granted Critical
Publication of JP5066088B2 publication Critical patent/JP5066088B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2008525054A 2005-08-04 2006-07-27 セロトニン受容体モジュレーターとしてのピリミジン化合物 Expired - Fee Related JP5066088B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US70571905P 2005-08-04 2005-08-04
US60/705,719 2005-08-04
PCT/US2006/029437 WO2007019083A1 (en) 2005-08-04 2006-07-27 Pyrimidine compounds as serotonin receptor modulators

Publications (3)

Publication Number Publication Date
JP2009503076A JP2009503076A (ja) 2009-01-29
JP2009503076A5 true JP2009503076A5 (ja�@�@) 2009-08-13
JP5066088B2 JP5066088B2 (ja) 2012-11-07

Family

ID=37400981

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008525054A Expired - Fee Related JP5066088B2 (ja) 2005-08-04 2006-07-27 セロトニン受容体モジュレーターとしてのピリミジン化合物

Country Status (16)

Country Link
EP (1) EP1928461B1 (ja�@�@)
JP (1) JP5066088B2 (ja�@�@)
KR (1) KR101353268B1 (ja�@�@)
CN (1) CN101277700B (ja�@�@)
AT (1) ATE539753T1 (ja�@�@)
AU (1) AU2006278759B2 (ja�@�@)
BR (1) BRPI0614397A2 (ja�@�@)
CA (1) CA2617760C (ja�@�@)
CR (1) CR9791A (ja�@�@)
EA (1) EA014495B1 (ja�@�@)
IL (2) IL189164A (ja�@�@)
NO (1) NO340744B1 (ja�@�@)
NZ (1) NZ565334A (ja�@�@)
UA (1) UA95247C2 (ja�@�@)
WO (1) WO2007019083A1 (ja�@�@)
ZA (1) ZA200802010B (ja�@�@)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2319539T3 (es) 2003-09-17 2009-05-08 Janssen Pharmaceutica Nv Compuestos heterociclicos condensados como moduladores del receptor de serotonina.
US7598255B2 (en) 2005-08-04 2009-10-06 Janssen Pharmaceutica Nv Pyrimidine compounds as serotonin receptor modulators
PE20080145A1 (es) * 2006-03-21 2008-02-11 Janssen Pharmaceutica Nv Tetrahidro-pirimidoazepinas como moduladores de trpv1
CN101652367A (zh) 2007-03-23 2010-02-17 辉瑞有限公司 作为5-ht2c激动剂的嘧啶并[4,5-d]氮杂卓衍生物
WO2009078999A1 (en) 2007-12-17 2009-06-25 Janssen Pharmaceutica N.V. Imidazolo-, oxazolo-, and thiazolopyrimidine modulators of trpv1
WO2011146089A1 (en) * 2010-05-21 2011-11-24 Abbott Laboratories Modulators of 5-ht receptors and methods of use thereof
CN106103434B (zh) 2014-05-29 2019-05-10 大鹏药品工业株式会社 四氢吡啶并嘧啶化合物或其盐
CN107365314B (zh) * 2016-05-11 2024-09-27 国药集团国瑞药业有限公司 一种吡唑类化合物、其晶型及其制备方法
IL309982A (en) * 2016-11-15 2024-03-01 Univ Temple New modulators of 5-hydroxytryptamine receptor 7 and a method of using them
US10562896B2 (en) 2017-05-31 2020-02-18 Chemocentryx, Inc. 6-5 fused rings as C5a inhibitors
WO2019126424A1 (en) * 2017-12-22 2019-06-27 Chemocentryx, Inc. DIARYL SUBSTITUTED 6,5-FUSED RING COMPOUNDS AS C5aR INHIBITORS
HRP20240793T1 (hr) 2018-04-18 2024-09-13 Constellation Pharmaceuticals, Inc. Modulatori enzima koji modificiraju metil, njihovi pripravci i upotreba
EP3797108B1 (en) 2018-05-21 2022-07-20 Constellation Pharmaceuticals, Inc. Modulators of methyl modifying enzymes, compositions and uses thereof
KR102282569B1 (ko) * 2019-02-08 2021-07-29 (주)퓨쳐켐 새로운 18F-표지된 친디엔체와 테트라진 화합물과의 IeDDA 반응을 이용한 18F-표지 방법
LT4003532T (lt) 2019-07-24 2024-11-11 Constellation Pharmaceuticals, Inc. 7-chlor-2- (4-(3-metoksiazetidin-1-il)cikloheksil)-2,4-dimetil-n-((6-metil-4-(metiltio)-2-okso-1,2-dihidropiridin-3-il)metil)benzo[d][1,3]dioksol-5-karboksamido kristalinės formos
KR102483492B1 (ko) * 2019-09-02 2023-01-02 한양대학교 에리카산학협력단 2,5-이치환된 피리미딘 유도체 및 이를 포함하는 약학적 조성물
CA3161590A1 (en) * 2019-11-13 2021-05-20 Temple University-Of The Commonwealth System Of Higher Education Novel functionalized lactones as modulators of the 5-hydroxytryptamine receptor 7 and their method of use
EP4681774A3 (en) 2021-03-29 2026-03-25 Gilead Sciences, Inc. Khk inhibitors
US12516064B2 (en) * 2022-02-02 2026-01-06 SpringWorks Therapeutics Inc. Tetrahydropyridopyrimidines and related analogs for inhibiting YAP/TAZ-TEAD
US12600723B2 (en) 2022-07-18 2026-04-14 Incyte Corporation Tetracyclic compounds as DGK inhibitors
US12600722B2 (en) 2022-07-18 2026-04-14 Incyte Corporation Tetracyclic compounds as DGK inhibitors

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3969355A (en) * 1974-11-01 1976-07-13 Morton-Norwich Products, Inc. 5-Aminoethyl-2,4-diphenylpyrimidine dihydrobromide
JPH03148265A (ja) * 1989-11-01 1991-06-25 Sumitomo Chem Co Ltd 5,7―ジフェニル―4,6―ジアザインダン誘導体、その製造法およびそれを有効成分とする除草剤
US5137890A (en) * 1990-02-14 1992-08-11 Ortho Pharmaceutical Corporation 4-phenyl tetrahydropyrido(4,3-d)pyrimidines
CA2188427C (en) * 1994-04-29 2000-06-27 Robert A. Volkmann Neurotransmitter release enhancers
WO1997047601A1 (en) * 1996-06-11 1997-12-18 Yoshitomi Pharmaceutical Industries, Ltd. Fused heterocyclic compounds and medicinal uses thereof
PL350884A1 (en) * 1999-04-01 2003-02-10 Pfizer Prod Inc Aminopyrimidines as sorbitol dehydrogenase inhibitors
US6806230B1 (en) * 1999-09-09 2004-10-19 Kumiai Chemical Industry Co., Ltd. Pyrimidine derivatives and herbicides containing them
AU2001241128A1 (en) * 2000-03-14 2001-09-24 Fujisawa Pharmaceutical Co. Ltd. Novel amide compounds
DE10111842A1 (de) * 2001-03-13 2002-09-19 Boehringer Ingelheim Pharma Antithrombotische Carbonsäureamide, deren Herstellung und deren Verwendung als Arzneimittel
ES2319539T3 (es) * 2003-09-17 2009-05-08 Janssen Pharmaceutica Nv Compuestos heterociclicos condensados como moduladores del receptor de serotonina.

Similar Documents

Publication Publication Date Title
JP2009503076A5 (ja�@�@)
US7598255B2 (en) Pyrimidine compounds as serotonin receptor modulators
RU2431635C2 (ru) Соединения и композиции в качестве ингибиторов активности каннабиноидного рецептора 1
KR101353268B1 (ko) 세로토닌 수용체 모듈레이터로서의 피리미딘 화합물
US20100016281A1 (en) Pyrimidine compounds as serotonin receptor modulators
CN118176198A (zh) 含氮的四环化合物、其制备方法及其在医药上的应用
AU2010245250B2 (en) Use of PDE7 inhibitors for the treatment of movement disorders
JP2020050682A (ja) ドライアイおよび他の目に関連する疾患を治療するためのヤヌスキナーゼ阻害剤
CN101557826A (zh) 泌尿系统疾病的治疗药
JP2000038350A (ja) 糖尿病治療薬
TW201333012A (zh) 咪唑并吡咯啶酮化合物
AU2013230128A1 (en) Pyrazolo[1,5-a]pyrimidine-based compounds, compositions comprising them, and methods of their use
ZA200603031B (en) Fused heterocyclic componds as serotonin receptor modulators
CZ20022222A3 (cs) Nové substituované pyrazolo [4,3-e] diazepiny, farmaceutické kompozice obsahující tyto diazepiny, jejich použití jako léčiva a způsoby jejich přípravy
KR20250048344A (ko) 만성 피로, 탈진 및/또는 운동 불내성과 연관된 질환의 치료 및 예방을 위한 포스포디에스테라제-7 억제 활성을 갖는 치료제의 용도
HK1118469B (en) Pyrimidine compounds as serotonin receptor modulators
CN101155787A (zh) (3,4-二氢-喹唑啉-2-基)-茚满-1-基-胺